• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:吴林霏,胡珊珊,黄嘉敏,沈红璋,张筱凤*.抗肿瘤抗体偶联药物靶向递送的研究进展[J].中国现代应用药学,2024,41(9):1281-1286.
WU Linfei,HU Shanshan,HUANG Jiamin,SHEN Hongzhang,ZHANG Xiaofeng*.Advances in the Targeted Delivery of Antibody Drug Conjugates[J].Chin J Mod Appl Pharm(中国现代应用药学),2024,41(9):1281-1286.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 285次   下载 312 本文二维码信息
码上扫一扫!
分享到: 微信 更多
抗肿瘤抗体偶联药物靶向递送的研究进展
吴林霏1, 胡珊珊1, 黄嘉敏1, 沈红璋2, 张筱凤*2
1.浙江中医药大学第四临床医学院,杭州 310005;2.杭州市第一人民医院消化内科,杭州 310005
摘要:
抗体与抗原结合的靶向递送是一种精准的递药方式,由于其高特异性和亲和力被视为理想的靶向递药方式之一,这为成功解决抗肿瘤治疗中化疗药物选择性差的问题开辟了新的道路。当前,利用单克隆抗体与靶抗原结合的抗体偶联药物(antibody drug conjugates,ADCs)研究成为分子靶向治疗的研究热点,本文就ADCs靶向递送的作用机制、靶向策略和靶向递送进展进行综述,以期为临床开发新的ADCs提供参考。
关键词:  靶向递送  抗体偶联药物  恶性肿瘤  治疗  进展
DOI:10.13748/j.cnki.issn1007-7693.20230840
分类号:
基金项目:国家自然科学基金项目(82304628);浙江省自然科学基金项目(LQ23H160047);浙江省医药卫生科技计划项目(WKJ-ZJ-2136)
Advances in the Targeted Delivery of Antibody Drug Conjugates
WU Linfei1, HU Shanshan1, HUANG Jiamin1, SHEN Hongzhang2, ZHANG Xiaofeng*2
1.The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310005, China;2.Department of Gastroenterology, Hangzhou First People Hospital, Hangzhou 310005, China
Abstract:
Targeted delivery of antibody bound to antigen is a precise drug delivery mode. It is regarded as one of the ideal targeted drug delivery modes due to its high specificity and affinity, which opens up a new way to successfully solve the problem of poor selectivity of chemotherapy drugs in antitumor therapy. Currently, the research on antibody drug conjugates(ADCs) that bind monoclonal antibodies to target antigens has become a research hotspot of molecular targeted therapy. This paper reviews the mechanism of action, targeting strategies and progress in the targeted delivery of ADCs, in order to provide reference for the clinical development of new ADCs.
Key words:  targeted delivery  antibody drug conjugates  malignant tumor  treatment  progress
扫一扫关注本刊微信